Polaris Group (TPE:6550)
Taiwan
· Delayed Price · Currency is TWD 38.25
+0.55 (1.46%)
Jun 25, 2025, 1:35 PM CST
Polaris Group Revenue
Polaris Group had revenue of 8.43M TWD in the quarter ending March 31, 2025, a decrease of -69.64%. This brings the company's revenue in the last twelve months to 87.67M, up 149.87% year-over-year. In the year 2024, Polaris Group had annual revenue of 107.00M with 1,330.29% growth.
Revenue (ttm)
87.67M
Revenue Growth
+149.87%
P/S Ratio
336.13
Revenue / Employee
531.34K
Employees
165
Market Cap
29.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107.00M | 99.52M | 1,330.29% |
| Dec 31, 2023 | 7.48M | 1.04M | 16.18% |
| Dec 31, 2022 | 6.44M | -8.60M | -57.19% |
| Dec 31, 2021 | 15.04M | 5.63M | 59.84% |
| Dec 31, 2020 | 9.41M | - | - |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Center Laboratories | 1.63B |
| TaiMed Biologics | 607.46M |
| Lumosa Therapeutics | 43.59M |